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Research Article
Dose-Response Analysis of Bromate-Induced DNA
Damage and Mutagenicity Is Consistent With
Low-Dose Linear, Nonthreshold Processes
Maria A. Spassova,1* David J. Miller,1 David A. Eastmond,2
Nadejda S. Nikolova,3 Suryanarayana V. Vulimiri,1 Jane Caldwell,1
Chao Chen,1 and Paul D.White1
1
National Center for Environmental Assessment (NCEA), Office of Research and
Development (ORD), U.S. Environmental Protection Agency (U.S.EPA), Washington, DC
2
Department of Cell Biology and Neuroscience, University of California, Riverside, California
3
Langley High School, McLean, Virginia

Mutagenic agents have long been inferred to act
through low-dose linear, nonthreshold processes.
However, there is debate about this assumption,
with various studies interpreting datasets as showing thresholds for DNA damage and mutation.
We have applied rigorous statistical analyses to
investigate the shape of dose-response relationships for a series of in vitro and in vivo genotoxicity studies using potassium bromate (KBrO3), a
water ozonation byproduct that is bioactivated to
a reactive species causing oxidative damage to
DNA. We analyzed studies of KBrO3 genotoxicity
where no-effect/threshold levels were reported as
well as other representative datasets. In all cases,
the data were consistent with low-dose linear models. In the majority of cases, the data were fit either by a linear (straight line) model or a model
which was linear at low doses and showed a satu-

ration-like downward curvature at high doses.
Other datasets with apparent upward curvature
were still adequately represented by models that
were linear at low dose. Sensitivity analysis of
datasets showing upward curvature revealed that
both low-dose linear and nonlinear models provide adequate fits. Additionally, a simple biochemical model of selected key processes in bromate-induced DNA damage was developed and
illustrated a situation where response for early primary events suggested an apparent threshold
while downstream events were linear. Overall, the
statistical analyses of DNA damage and mutations
induced by KBrO3 are consistent with a low-dose
linear response and do not provide convincing
evidence for the presence of a threshold. Environ.
C 2012
Mol. Mutagen. 00:000–000, 2012. V
Wiley Periodicals, Inc.
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INTRODUCTION
Dose-response patterns for induction of mutations and
other genotoxic effects induced by radiation and exogenous
chemical agents have long been inferred to be linear
[Ehling et al., 1983; Grosovsky and Little, 1985; Poirier
and Beland, 1994; Frantz et al., 1995; Jansen et al., 1995].
Abbreviations: AIC, akaike information criterion; BrOI, reactive oxygen
intermediates formed by KBrO3 interaction with GSH; BMDS, EPA’s
benchmark dose software; COM, comet assay; GSH, glutathione; gMM,
generalized Michaelis-Menten model; HPRT, mutations at the HPRT locus;
KBrO3, potassium bromate; LOEL, lowest-observed-effect-level; mB, multiplicative binomial distribution; MNC, micronucleated cells; MLE, maximum likelihood estimates; NCE, normochromatic erythrocytes; NOEL, noobserved-effect-level; Ogg1, 8-oxoguanine DNA glycosylase; OGG1R,
Ogg1 initiated base-excision repair mechanism; PCE, polychromatic erythrocytes; ROS, reactive oxygen species; 8-OH-dG,8-hydroxy-2-deoxyguanosine; SSB, single strand break; Tk, thymidine kinase.

The inference of a linear dose-response for mutagenesis
has also served as support for inferring the likelihood of
low-dose linearity in carcinogen risk assessment. U.S. EPA
guidelines for carcinogen risk assessment recommend that
a linear low-dose extrapolation approach be used for the
risk assessment of carcinogens which are mutagens that
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directly interact with DNA. Various other authoritative
bodies such as the World Health Organization’s Regional
Office for Europe, the International Programme for Chemical Safety, the European Commission, and Health Canada have also incorporated information on genotoxicity
into their carcinogen risk assessment guidelines [European Commission, 1996; Zeiss et al., 1999]. However,
there has been debate in the scientific literature about the
assumption of linearity in the action of mutagens [Henderson et al., 2000; Bolt et al., 2004; Pottenger and Gollapudi, 2009]. Various studies have interpreted experimental dose-response data as showing thresholds in the doseresponse of DNA damage and mutation induced by genotoxic agents [Doak et al., 2007; Yamaguchi et al., 2008;
Platel et al., 2009; Gocke et al., 2009; Seager et al.,
2012]. However, rigorous statistical analyses of the doseresponse dependence have not commonly been performed. Recent publications have applied statistical methods with a goal to identify a threshold point below which
there is no response to a genotoxic agent (c.f. [Johnson
et al., 2009; Lutz and Lutz, 2009; Seager et al., 2012]).
Here we illustrate the use of an analytical approach to
examine the shapes of dose-response relationships in
experimental studies of mutagenesis and related measures
of genotoxicity. In particular, we examine the consistency
of these datasets with dose-response models that are lowdose linear. At the outset it is important to note that such
low-dose linear models do not imply a fully linear
(straight line) response over an entire experimental dataset. In particular, a variety of effects involving, for
example, saturation of metabolic processes or occurrence
of overt cellular toxicity may cause observed doseresponse patterns to show upward or downward curvature
at higher doses. Thus, the empirical question of interest
here regards the shape of observed dose-response patterns
at lower (but necessarily experimentally accessible)
dose levels.
For this study, we focused on an example where genotoxicity is related to oxidative damage to DNA. We have
examined datasets of mutagenic and related genotoxic
effects of potassium bromate (KBrO3), a carcinogen that
induces oxidative damage to DNA and has been considered to likely have a genotoxic mode of action [IARC,
1999; Moore and Chen, 2006]. KBrO3 was selected
based on the multiple lines of evidence indicating that
KBrO3 and/or its metabolites directly interact with DNA
residues to produce oxidative DNA damage [IARC,
1999; Arai et al., 2003; Ballmaier and Epe, 2006; Moore
and Chen, 2006]. The damage is reported to occur following KBrO3 bioactivation that involves cellular reductants such as glutathione (GSH) and produces an active
intermediate. This unknown intermediate generates
8-hydroxy-2-deoxyguanosine (8-OH-dG) DNA adducts
[Murata et al., 2001;Ballmaier and Epe, 2006]. This is
considered the initiating step for further DNA alterations

including single-strand and double-strand DNA breaks
(SSB and DSB), deletions and mutations. Based on this
theory, extracellular and intracellular GSH concentrations
may influence the dose-response dependence and interindividual or animal variability. Note that analyses
presented in this paper concentrate on the examination of
available data on DNA damage and mutations induced
by KBrO3; an analysis of the mode (or modes) of action
for KBrO3 in the induction of cancer involves a
variety of other scientific issues and is not addressed in
this paper.
Numerous dose-response studies have been conducted
on the genotoxicity and mutagenicity of KBrO3 using
acellular and cellular systems as well as experimental animals. It has been reported that at the molecular (cell-free)
level, DNA damage by KBrO3 follows linear doseresponse dependence. For example, when bacteriophage
PM2 DNA was used in a relaxation assay, DNA damage
increased linearly with concentrations of KBrO3 between
0.1 and 1 mM when incubated in the presence of glutathione (GSH) [Ballmaier and Epe, 1995; Ballmaier and Epe,
2006]. Similarly, using calf thymus DNA, Murata et al.
[Murata et al., 2001] measured 8-OH-dG formed by
KBrO3 and its dependence on the presence of GSH and
several other thiol-containing peptides. Their data also did
not show any indication of sublinearity, when visually
inspected. However, in cellular and whole animal systems
there have been a variety of different results presented in
the literature regarding the shape of dose-response dependence.
In this study we provide an organized statistical examination of dose-response patterns observed in experiments
for a range of test systems examining DNA damage and
mutagenesis by KBrO3. As evident from the examples
presented, a large number and variety of genotoxicity
studies have been conducted for KBrO3 in vitro and in
vivo using a wide range of concentrations or doses. The
objective of our study was to perform more formal and
rigorous dose-response modeling of the KBrO3 genotoxicity data with a particular emphasis on the types of damage believed to be most relevant to direct-acting oxidative
mutagens. In particular, we wanted to examine the degree
to which reported data were consistent with low-dose linear relationships, or, alternatively, were indicative of relationships showing either strong sublinear or supralinear
patterns. We approached this evaluation by first identifying the studies for each of several important types of test
systems that would best support statistical examination of
the dose-response. Results of dose-response model fitting
and graphical analysis are presented for each of these
studies. Finally, we developed a simplified biochemical
model to provide insight into how different biological
processes can affect observed dose-response patterns. Biochemical modeling can illuminate differences in doseresponse patterns that may be seen between early effects
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such as adduct formation and downstream processes such
as single-strand DNA breakage.
METHODS
Study Selection
Prior to performing the dose-response analyses, an extensive review
of the literature was conducted to identify studies that would be the
most informative and relevant for dose-response modeling. We considered both in vitro and in vivo studies that measure KBrO3 induced
DNA damage using various genotoxicity assays. Examples from both
categories were selected for further analyses based on the criteria
described below. A table summarizing the studies that were considered
is shown in the Appendix, Table AI. Studies were prioritized for subsequent analyses using scientific judgment generally based on the following considerations: (1) Higher priority was given to types of genetic
damage such as 8-OH-dG adduct formation, DNA strand breakage,
micronucleus formation and deletion mutations, which have been
shown to be the most sensitive to oxidative mutagens [Moore and
Chen, 2006; Luan et al., 2007]; (2) Results from experiments using
mammalian cells in culture or those using laboratory animals (mice or
rats) were favored over those conducted in acellular systems or using
non-mammalian species; (3) Studies that used the widest range of test
concentrations or administered doses were also given priority; (4) Studies that used the lowest doses, capable of revealing the shape of the
dose-response at the low-dose region were given high priority; and (5)
In vivo studies conducted using an oral route of exposure were generally preferred to those which used parenteral routes of administration.
In selecting studies, we made an effort to include relevant publications
where the authors had suggested that data indicate sublinear/threshold
behavior. For each major class of genotoxic effect being considered,
one, or occasionally two, representative studies were selected for
detailed dose-response modeling.

Statistical Analysis
Dose-response analysis was carried out using EPA’s benchmark dose
software (BMDS) and original scripts in MATLAB. The results were
plotted using MATLAB or Origin software. We used a likelihood
approach to evaluate the dose-response models’ goodness-of-fit. The
likelihood was evaluated under the assumption of binomial, log-normal
or normal distributions of the responses. As a general approach, we
examined data to see if it was consistent with a simple linear (straightline) relationship, where response was proportional to dose. In situations where the data indicated curvature in response, we used models
consistent with the pattern of response observed. When data showed
downward curvature suggestive of a plateauing of response, we examined the fit of Michaelis-Menten type models, exponential models
[Slob, 2002] or a generalization of the Michaelis-Menten model (a
bent-hyperbola model) as discussed further below. The bent-hyperbola
model also allows for a fit of data that appear to have a ‘‘change
point’’ between two linear segments of the dose-response. For data
showing upward curvature or more complex patterns of response, we
examined the fit of the bent-hyperbola model and models from an exponential family [Slob, 2002]. These exponential models have important features in that they describe various irreversible biological processes. Additionally, an exponential model can reflect data that show
upward curvature at higher doses but may be consistent with a more
linear response at low dose. We also conducted analyses examining the
comparative fit of exponential models, quadratic models and hockey
stick (threshold) model for datasets showing upwards curvature.
Mathematically, a low-dose linear relationship may be defined as one
that has a positive slope extending down to the zero dose control group

3

(slope > 0 at dose50). For practical considerations it is also important
to understand the magnitude of the estimated low dose response as
compared with responses in the observed study range. To provide an indicator of the relative magnitude of the low dose slope, we have calculated the ratio of the slope at the lowest-observed-effect-level (LOEL)
divided by the slope at zero. An index value of one would suggest a
highly linear response in the low dose region (for doses extending up to
the observed LOEL). On the other hand a large value of the index would
indicate a low dose slope that is small in comparison with slopes at the
LOEL. Finally a small value of the index would indicate a low dose
slope that exceeds the slope at the LOEL. Here we were particularly
concerned with data with upward curvature that might suggest a threshold, and we have used this slope index in interpreting modeling results
for these datasets.
A goodness-of-fit p-value and the Akaike information criterion (AIC),
a commonly employed statistical approach to allow comparison of fit
across model types, were used to judge the appropriateness of the models. The AIC is defined as 22L 1 2p, where L is the log-likelihood at
the maximum likelihood estimates (MLE) for the model parameters, and
p is the number of model parameters estimated. A likelihood-ratio test
that compares the full model to each dose-response model was used to
derive the goodness-of-fit p-values. The full model allowed the mean to
vary independently across doses. We considered a model appropriate if
the p-value was > 0.1. Unless otherwise noted, the data are plotted with
their 95% confidence limits.
Cell culture data were tested by binomial dispersion test to define
the homogeneity between replicas where applicable. Binomial
dispersion test was performed after Richardson et al. [1989] with test
statistics:

X2 ¼

ri
d X
X
ðzij  kij p^i Þ2
i¼0 j¼1

kij p^i ð1  p^i Þ

ð1Þ

;

where d is the number of doses, with i 5 0 being the control, ri is the
number of replicates in the ith dose, pi is the proportion of aberrant cells
in the ith dose group (number of aberrant cells summed over the replicate cultures exposed to dose i divided by the total number of cells
sampled at dose i), kij is the number of cells sampled from the jth replicate culture exposed to dose i, among which the number of aberrant cells
was zij. The test statistics was compared to a v2 distribution with
Pd
i¼0 ðri  1Þdegrees of freedom.
In one analysis, the test revealed significant underdispersion in a data
set [Platel et al., 2009], with p-value < 0.001. To properly model the
responses distribution we used a generalization of the binomial distribution capable of modeling underdispersed data. More specifically, the
multiplicative binomial (mB) distribution [Altham, 1978] was used to analyze the data from Platel et al. [2009]:

PrðZk ¼ jÞ ¼
f ðp; u; kÞ ¼

 
k pj qkj ujðkjÞ =f ðp; u; kÞ;
j

k  
X
k pj qkj ujðkjÞ
j¼0

j

ojk
ð2Þ

The mB distribution contains an additional parameter y > 0 as compared to the binomial distribution [Eq. (2)] and allows for modeling of
overdispersed (y < 1) or underdispersed (y > 1) data, where 0 < P 5
1-q < 1. The indices have their usual meaning for binomial distribution
– k is the sample size and j is the number of successes. Zk here is a random variable that represents the number of aberrant cells out of k cells.
More specifically Zk is the sum of random variables X1,. . ., Xk, which
represent the response of each cell with possible values 0 (normal) and 1
(aberrant). The assumption for derivation of the multiplicative binomial
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distribution is that X1,. . ., Xk are identically distributed but not independent variables with symmetric joint distribution and no second- or higherorder interactions ( no three-variable interaction). To apply the model for
dose-response data we assumed that y is dose independent.
To model dose-response shapes that showed saturation that was not
well fit by a Michaelis-Menten model or where there was an apparent
change point between two linear slopes, we used a generalization of the
Michaelis-Menten model (gMM) also known as bent-hyperbola model
[Ridout, 1994]. To fit data showing saturation, the model was modified
to have a horizontal positive asymptote as follows:

E½yjx ¼ u0 þ u1 ðx  aÞ  u1

qﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðx  aÞ2 þ g

ð3Þ

This modified model has low-dose linear properties and saturates at
high doses. Furthermore the model allows for more flexible transition to
saturation (either faster or slower) compared with the classical Michaelis-Menten model.
The bent-hyperbola model can also be modified to a hockey stick
model with a horizontal negative asymptote and a sharp bend between
the two slopes:

E½yjx ¼ u0 þ u1 ðx  aÞ þ u1

qﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðx  aÞ2 þ g;

ð4Þ

pﬃﬃﬃ
where g 5 1026. The specification of this small fixed value of g
causes the hyperbola to have a very tight ‘‘change point’’ (bend) and
represent a hockey stick model. This threshold model was used to fit the
data from Seager et al., 2012 and compare their AIC values to that of
the low-dose linear nonthreshold model.

Biochemical Kinetic Model
The biochemical model developed here contains elements reflecting a
series of processes involved in DNA damage by bromate: interaction
with a biomolecule (here represented by GSH) to form a DNA reactive
species, production of DNA adducts, and the presence of a repair process
that removes adducts. This repair process can also result in error leading
to production of strand breaks, although at a much lower rate than successful repairs. This model is not intended to be predictive of rates of
DNA damage in vivo or in vitro, as the current understanding of the
processes involved is insufficient to support a predictive model. Rather,
the model is intended to support further quantitative understanding of
how different processes involved in this system can interact and how
this may influence shapes of dose-response relationships. The biochemical model contains a series of bromate- and oxygen-derived molecules
that participate in the following eight chemical reactions:
KBrO3 ! BrO
3
GSH þ BrO
$ GSH:BrO
3
3
GSH:BrO3 ! GSH þ BrOI
BrOI þ Guanine $ BrOI:Guanine
BrOI:Guanine ! BrOI þ 8-OH-dG
8-OH-dG þ OGG1R $ 8-OH-dG:OGG1R
8-OH-dG:OGG1R ! OGG1R þ Guanine
8-OH-dG:OGG1R ! OGG1R þ SSB
where the dot notation signifies a bound complex of two participants.
Some of these reactions are based on those proposed by Kawanishi and
Murata [2006]. Via interaction with reduced glutathione (GSH), an intermediate product (BrOI) is formed, which can form the oxidative lesion
8-OH-dG on DNA. These lesions can subsequently be repaired by an
appropriate repair mechanism (which we label OGG1R), or alternatively
a single strand break can persist due to a failed repair attempt. The
model elements Guanine, GSH, and OGG1R were given appropriate initial values and KBrO3 was dosed at time zero. The reactions were modeled using simple mass-action kinetics, with all simulations carried out

using MATLAB SimBiology software. In the absence of repair, OGG1R
binding rates were set to zero.

RESULTS AND DISCUSSION
In Vitro Studies
Following the initial screen and study selection, we
used dose-response modeling to analyze the data from
four studies conducted to investigate the genotoxic and
mutagenic effects of KBrO3 in mammalian cell culture
systems. First, we focused on a recently reported KBrO3
genotoxicity study, where the results were interpreted by
the authors as showing a threshold [Platel et al., 2009].
As described in the study report, TK6 human lymphoblastoid cells were exposed to various concentrations of
KBrO3 between 6.25 lM to 5 mM for 1 to 24 h, and the
cells were harvested for the micronucleus test 24 hr after
the beginning of exposure.
A binomial dispersion test [Richardson et al., 1989]
was used on the experimental replicates to determine if
the responses followed a binomial distribution. The test
revealed no overdispersion. Instead, underdispersion was
encountered as compared with the expected binomial distribution dispersion, with P-value 5 0.001 (see Methods).
Underdispersion might reflect some type of cell–cell interaction in the cell suspension or could be a result of a procedural matter that was not apparent to us in this review.
To appropriately analyze the data, we used a generalized
binomial distribution named multiplicative binomial (mB)
[Altham, 1978]. While the response’s distribution was
modeled with mB, the concentration dependence of the
responses was modeled with a linear function for the data
from the experiments using the 1, 2, and 3 hr periods of
exposure (Figs. 1A–1C).
We used a likelihood approach to test the appropriateness of the model. The likelihood of the model was compared to a full model in a likelihood ratio test (goodnessof-fit test). The high goodness-of-fit P-values for this test,
between 0.38 and 0.92, suggest that a linear model is
highly appropriate (Figs. 1A–1C). In contrast, the data
from 24 hr of exposure (Fig. 1D) showed some clear saturation of the response at high concentrations. After determining that a Michaelis-Menten model in BMDS (dichotomous Hill with slope 5 1) did not provide an adequate
fit, we modeled these using a generalization of the
Michaelis-Menten model (gMM) also known as the benthyperbola model [Ridout, 1994]. The model was modified
to have zero slope of the positive asymptote (Eq. 3). As
before, a likelihood-ratio test was used to define the
appropriateness of the model and gave P 5 0.95, indicating that the model is highly consistent with the data.
The dose-response analysis of the data reveals high
consistency with low-dose linear models and thus is not
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Fig. 1. DNA damage in TK6 human B-lymphoblastoid cells measured
using the micronucleus assay. A–D: Micronucleated cells (MNC) formed
at various concentrations and times of exposure to KBrO3 based on data
from Platel et al. are shown [Platel et al., 2009]. The data were assumed
to follow a generalized binomial distribution [Altham, 1978] that allows
for modeling underdispersed data (see text). A likelihood approach was
used for the statistical analysis. A–C: A linear model was fit to the three
sets of data at the low exposure times (1, 2, and 3 hr). D: A generalization of Michaelis-Menten equation [Ridout, 1994], also known as a
bent-hyperbola model, was used to model the data following the 24-hr
exposure that shows saturation at high doses. This model retains the low

dose linear behavior of the Michaelis-Menten model, but allows for
data-dependent curvature to predict more rapid saturation as compared
to the Michaelis-Menten model. The goodness-of-fit P-values are indicated for each dataset and show a high adequacy of the models. E: The
slope parameter MNC/[KBrO3] from A–D, is plotted vs. time of exposure. For D, approximation of the slope was defined from y1 (Eq.2) as
in this case a2  g. The 90% confidence intervals defined by the profile-likelihood method [Crump and Howe, 1985] are shown as error
bars. The time dependence was fit with an exponential model [Slob,
2002]. The model predicts maximal potency MNC/[KBrO3] of 0.19
(see text).

indicative of a threshold for this response. In addition, the
data from this study allowed us to analyze the potency of
unit concentration of KBrO3 to induce micronucleated
cells (MNC) as a function of time (MNC/[KBrO3] vs.
time of exposure, Fig. 1E). Such analysis can allow us to
define the maximal potency of KBrO3 as a measure of the
full clastogenic potency of this chemical. For the 24 hours
exposure data modeled by the gMM model, we used the
slope at the low dose region to define MNC/[KBrO3]
(Fig. 1D). As the gMM model parameter a2 was much
larger than g (a2  g) at its MLE, the slope in the low
dose region was approximately defined by y1 (Eq. 3). The
time dependence of MNC/[KBrO3] is plotted on Figure
1E. While a linear model did not fit the data, an exponential model was fit to the data with high goodness-of-fit (p
5 0.72). The maximal potency MNC/[KBrO3] was predicted by the model as 0.19,  50% higher than the experimental maximum. This value could be a useful char-

acteristic for comparing the genotoxicity of different
chemicals.
A recent study on oxidative stress-induced genotoxicity
was designed to examine the low dose responses to several chemicals, including KBrO3, in the human B-lymphoblastoid AHH-1 cell line. An HPRT forward mutation
assay and a cytokinesis-block micronucleus assay were
performed [Seager et al., 2012]. These authors analyzed
their data using a hockey stick model [Lutz and Lutz,
2009] and reported threshold estimates for the KBrO3
data from both assays with a positive lower bound estimate for the threshold. When the lower bound of the
threshold is positive, it provides statistical evidence that
the threshold model is better than a perfectly linear model
[Crump, 2011]. We reanalyzed the data from these experiments using continuous dose-response models (as discussed in Methods) and examined the goodness-of-fit of
the models to the data. Our analysis indicated that the
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Fig. 2. KBrO3 induced DNA damage in lymphoblastoid AHH-1 cell
culture measured by HPRT forward mutation assay and cytokinesisblock micronucleus assay [Seager et al., 2012]. A: HPRT mutation frequency was quantified after exposure to various concentrations of
KBrO3 for 24 h. The data were fit with exponential dose-response model
([Slob, 2002], model 2) with power model of the variance that provided

adequate fit with a goodness-of-fit p-value of 0.37. B: Micronucleus
assay data from 24-hr exposure to KBrO3 at various concentrations are
plotted. Log-normal distribution of the responses was assumed and an
exponential model ([Slob, 2002], model 2) with low dose linear properties was fit to the data with high goodness-of-fit P 5 0.63 value.

data on the HPRT mutations are also consistent with an
exponential low-dose linear model ([Slob, 2002], model
2) with a p 5 0.37 (Fig. 2A). The data from the MN
assay in the same study showed high overdispersion in
the high dose region and were overdispersed overall.
Therefore, models where the variance is estimated from
the data were considered. As the MNC frequency was
low, skewness of the data distribution was assumed and a
log-normal distribution was used to represent the observed
variability. The fully linear dose-response model did not
provide an adequate fit for the MN data, consistent with
the original analysis by Seager et al. [2012]. Upon further
examination, we found that the data were well fit by an
exponential model ([Slob, 2002], model 2) that is linear
at low dose. The goodness-of-fit p-value of 0.63 indicates
that the data are highly consistent with the exponential
model (Fig. 2B). To compare the exponential model fits
with the original analysis by Seager et al. [2012], we
computed the AIC value for the hockey stick model fits
(see Methods) and the exponential model fits. We used
constant variance for both models as it is analogous to
the least square fit procedure used by Seager et al. [2012].
The use of this approach did confirm the threshold values
reported by Seager et al. [2012] as the MLE of the
hockey stick model. The analysis of the HPRT data with
the hockey stick model and the exponential model both
provided an AIC value of 139, indicating that the data do
not support one model over the other. Similarly, for the
MN data, the hockey stick model gave an AIC value of
19, while the exponential model provided a lower but
close AIC value of 17.
Another study investigated KBrO3 induced DNA damage in TK6 cell cultures using the comet assay (COM)
and MN test [Luan et al., 2007]. Visual inspection of the
MN dose-response data in this study showed close to lin-

ear dependence with some suggestion of supralinearity at
low doses. These data are consistent with our analysis of
the Platel et al. data that supports low-dose linear dependence [Platel et al., 2009]. However, the COM assay data
provided some suggestion of sublinearity, with the mean
response of the first dose being numerically below the
control level. We analyzed the dataset from the alkaline
COM assay to test if it was consistent with a linear doseresponse model. The neutral COM assay data presented
some more pronounced nonmonotonic behavior that needs
further investigation and we did not further analyze that
data. A linear model with variance as a power function of
the response fit the alkaline COM data with high goodness-of-fit value p 5 0.72 (Fig. 3A), showing that a linear
model appropriately represented this dataset. Here we
want to clarify again that the consistency of the data with
low-dose linear models does not definitively address the
question of whether a biological threshold in response
exists. We would note that this data set, given the spacing
of the experimental doses and the observed variances, has
little power to discern the nature of the dose-response
relationship below the 1 mM concentration.
The genotoxic potency of KBrO3 has also been investigated using a mouse lymphoma assay which measures
mutations affecting the thymidine kinase (Tk) gene in
L5178Y/Tk1/2 cells. This assay is widely used due to its
ability to detect both point and chromosomal mutations.
In a study by Harrington-Brock et al. [2003], the doseresponse of Tk mutations induced by KBrO3 was determined. We used the data from this study to model the
mutation frequency induced by KBrO3. We assumed a
normal distribution of the response with variance estimated from the data. In this dataset, the responses at the
highest dose levels indicated a greater than linearly proportional response. The dose-response was successfully fit

Environmental and Molecular Mutagenesis. DOI 10.1002/em
Low-Dose Linearity of Bromate Genotoxicity

7

Fig. 3. KBrO3 induced DNA damage in cell cultures measured by comet
assay and Tk mutant frequency. A: Alkaline comet assay as a measure of
DNA damage was performed on TK6 cells treated with KBrO3 for 4 hr.
The data were reproduced from Luan et al. [Luan et al., 2007]. Linear
model with modeled variance (BMDS) was fit to the data with a goodness-of-fit P-value 5 0.72. B: Tk mutant frequency of L5178Y/Tk1/2

mouse lymphoma cells after 4 hr. incubation with KBrO3 [HarringtonBrock et al., 2003]. As regression analysis did not reveal significant differences between the two experiments, we analyzed the combined data
from the two experiments, using a normality assumption, where the variance was estimated from the data. The dose-response was modeled with
a bent-hyperbola model that yielded a P-value of 0.29.

by a bent-hyperbola model which fit the data with an acceptable level of likelihood compared to the full model
with P 5 0.29 (Fig. 3B). The low-dose linearity index
(see methods) was 1 in this case. Once again, low-dose
linearity was highly consistent with the data according to
our statistical modeling.

for MN formation after in vivo exposure to KBrO3. CD-1
male mice were dosed by single intraperitoneal injections
administering KBrO3 at doses ranging from 18.8 to 212
mg/kg [Awogi et al., 1992]. Blood was collected 0–96 hr
after injection of KBrO3. Two independent studies, by
Nippon Glaxo, Tokyo Research (NGTR) and Otsuka
Pharmaceutical Factory (OPF), are summarized in the article. We chose to model the OPF study data as it
included an additional lower dose. We used the data from
samples collected 24 hr after exposure, as they were collected at a commonly used time point for the MN test.
Similar increases in MN were also seen at the 48 hr sampling period. There was a decrease in the response at the
highest dose (212 mg/kg) at 24 hr, and so this data point
was not used in the analysis. Again a log-normal distribution of the responses was assumed for reasons similar to
those described earlier. We modeled the dose-response
with an exponential model ([Slob, 2002], Model 4),
another model which exhibits low-dose linear behavior.
The goodness-of-fit P-value of 0.81 revealed that the
model was highly consistent with the data (Fig. 4B).
Based on our analysis and the overall review of the data,
we conclude that in vivo genotoxicity of KBrO3 in the
bone marrow is consistent with linear behavior across the
range of doses tested.
To address another important aspect in characterizing
genotoxicity, we investigated the shape of the doseresponse in one of the target organs, where tumor development has been detected. After careful review of the literature, we selected a study investigating genotoxicity in
rat kidney cells after KBrO3 exposure. The study had the
most extended dose range toward low doses and a significant response was only observed at the high dose point of
500 ppm KBrO3 in drinking water, leading the authors to
suggest the existence of a no-effect level [Yamaguchi

In Vivo Studies
Further, we were interested in the dose-response shape
of the DNA damage caused by KBrO3 in vivo. Allen
et al. [2000] used B6C3F1 male mice treated with KBrO3
in drinking water at doses ranging from 0.08 to 0.8 g/L
for 8 or 78 weeks. The rates of MN induction were determined in peripheral blood normochromatic and polychromatic erythrocytes (NCE and PCE, respectively). None of
the four datasets, for two different treatment times and
two different cell types, showed signs of sublinearity in
the dose-response dependence, except possibly in the case
of the MN in the PCEs after 78 weeks of exposure. The
responses showed low frequency of the MN (maximum 6/
1,000), a circumstance that can lead to a suggestion of
some skewness of the distribution of the response. Therefore, we assumed a log-normal distribution of the
responses. We analyzed the MN-NCE after 78 weeks of
exposure. We chose the NCE for the analysis as they
reflect more persistent KBrO3 effects. A MichaelisMenten model (linear at low dose and saturating at high
doses) was used to fit the dose dependence of the MNNCE after 78 weeks of exposure to allow for observed
downward curvature at the higher doses in this dataset.
The Michaelis-Menten model gave a goodness-of-fit Pvalue of 0.11, which indicates the model is consistent
with the data (Fig. 4A). Another similar study performed
by Awogi et al. [1992] examined peripheral blood PCE
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Fig. 4. Micronucleus (MN) induction by KBrO3 in mice blood cells in
vivo. Log-normal distribution was assumed for these data. The geometric mean responses with the 95% CI are plotted vs. KBrO3 concentration. A: Effects of chronic (78 weeks) exposure to KBrO3 in drinking
water of B6C3F1 mice [Allen et al., 2000]. Data on peripheral blood
normochromatic erythrocytes have been fitted with a Michaelis-Menten

model. B: Micronucleus test results from the peripheral blood polychromatic erythrocytes of CD-1 male mice dosed with KBrO3 (mg/kg) by intraperitoneal injection [Awogi et al., 1992]. The blood was collected 24
hr after the KBrO3 injection. The dose-response has been modeled with
an exponential model ([Slob, 2002], Model 4). The P-value of 0.81
reveals that the model is highly consistent with the data.

et al., 2008]. Furthermore, Yamaguchi et al. [2008]
employed the NaI DNA isolation method with deferoxamine mesylate as a chelating agent. Such an approach
should minimize the artifactual formation of 8-OH-dG
during DNA isolation. Big Blue rats were treated for 16
weeks with KBrO3 dissolved in their drinking water at
concentrations between 0.02 and 500 ppm. Kidney genotoxicity was assessed by quantifying 8-OH-dG DNA
adducts in kidney cells and point mutations, including
GC->TA in the lacI gene of the transgenic rats. 8-OH-dG
is considered to be the primary form of DNA damage by
KBrO3. However, because GC->TA transversion mutations have not been directly associated with 8-OH-dG frequency [Nakajima et al., 2002; Arai et al., 2003], we
focused our analysis on the dose-response data of 8-OHdG. These data were adequately fit with a linear (straight
line) dose-response with P-value 5 0.15 (not shown). We
performed sensitivity analysis to examine the ability of
these data to distinguish between different dose-response
models. As the plot indicates some upward curvature, an
exponential model was fit to the data (Fig. 5A). The
goodness-of-fit test gave P 5 0.23, which indicates that
the model appropriately describes the data. The low-dose
linear properties of this model are apparent on the inset
of Figure 5A. Because of the wide range of doses
employed, a semi-logarithmic plot (Fig. 5B) is also shown
to reveal visually the goodness-of-fit. Note however, that
frequently used semi-logarithmic plots give distorted
impressions of the dose-response shapes, as even a
straight line will appear to have upward curvature when
so plotted. Given that these data suggest an upward curving response, we also fit a quadratic model with no linear
term to the data (Fig. 5C). This model also fit the data
appropriately (goodness-of-fit p 5 0.35). To further com-

pare different models we used the AIC that is based on
the likelihood values, but also penalizes for each
additional model parameter. The three models (linear, exponential and quadratic) had sufficiently close AIC values
of 2100, 2112, and 2114, respectively. Overall, statistical modeling showed that this dataset had little power to
resolve the shape of the underlying dose-response relationship and could be fit with models that were linear as
well as models that were nonlinear at low dose.
The process of DNA damage by KBrO3 is believed to
start with generation of 8-OH-dG DNA adducts, though
some evidence suggest that SSBs can be generated
directly by KBrO3 under cell-free conditions [Ballmaier
and Epe, 2006]. The 8-OH-dG adducts are repaired by a
base-excision repair (BER) mechanism, where the first
step is the adduct’s excision by 8-oxoguanine DNA glycosylase (Ogg1). At this point, a single-strand break
(SSB) is created. In some cases further repair might fail
and result in an accumulation of SSBs. Large deletion
mutations can arise from double strand breaks (DSBs) or
adjacent SSB, and it has been demonstrated that this type
of mutation accounts for 90% of the mutations induced
by KBrO3 in TK6 lymphoblastoid cells [Luan et al.,
2007]. Accordingly, large deletion mutations are considered to be a major mode of KBrO3 genotoxicity. We
therefore considered DNA deletions in the kidney, a target organ, to be an important end point. We investigated
the dose-response relationship of KBrO3-induced deletion
mutations in kidney cells using a study by Umemura
et al. [2006] in which the authors measured the Spi2 deletion mutation frequency in the kidneys of gpt delta rats
exposed to KBrO3. KBrO3 was added to the drinking
water at concentrations between 60 and 500 ppm for
13 weeks. Again, we were interested to find if low-dose
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Fig. 5. Dose-response dependence of DNA oxidation in the kidney, a
target organ of KBrO3 carcinogenesis. Big Blue rats were exposed to
KBrO3 added to their drinking water for 16 weeks. Data on 8-OH-dG/
105 dG bases of DNA extracted from the kidneys [Yamaguchi et al.,
2008] are plotted vs. KBrO3 concentration. We analyzed the data using
two models: (1) low-dose linear model and (2) a model with zero slope
at zero dose. We used an exponential model ([Slob, 2002], Model 2)
with low-dose linear behavior (A–B) and a quadratic model with a

zeroed linear term (C), respectively. The exponential model is presented
in linear coordinates in A. The low-dose dependence (A inset) is indistinguishable from linear. The data are plotted on a semilogarithmic scale
(B–C) to reveal visually similar goodness-of-fit of both exponential and
quadratic models. Both models adequately fitted the data with close
Akaike information criterion (AIC) values of 2114 and 2112 respectively, indicating that the actual shape of the dose-response curve cannot
be resolved from the existing data.

linear models can give appropriate fit to the data. As these
data were not adequately fit by linear (straight line) models in BMDS and the plot indicated some upward curvature, an exponential model ([Slob, 2002], model 2) with
low-dose linear properties was fit to the data (Fig. 6). A
log-normal distribution of the response gave an improved
fit to the data with a goodness-of-fit P-value P 5 0.11.
The appropriate fit of the model also indicates that for
this important end point low-dose linearity is consistent
with the data.
Using KBrO3 as an example, we investigated the shape
of the dose-response for a number of genotoxicity and
mutagenicity endpoints across multiple studies. Specifi-

cally, we were interested in determining if linearity at
low doses is a common feature of the dose-response
relationships for this agent that acts directly and/or
through its metabolites to induce oxidative damage to
DNA. KBrO3 was selected as a genotoxic agent that
repeatedly has been shown to be carcinogenic in male
and female rats, and is probably carcinogenic in mice and
hamsters [Kurokawa et al., 1990; DeAngelo et al., 1998;
IARC, 1999]. Our analysis of different endpoints at the
cellular and organismal levels showed overall consistency
with low-dose linear models. We found that each data set
we examined could be appropriately fit by models that
have linear behavior at low dose. Low-dose linear models
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Fig. 6. Deletion mutations in the kidneys of gpt delta rats exposed to
KBrO3. Dose-response data from Umemura [2006] are plotted. An exponential, low-dose linear, model ([Slob, 2002], model 2) is fit to the data
for Spi2 mutation frequency as a measure of deletion mutations. A lognormal distribution of the data at each concentration was assumed and a
log-scale constant variance model was used.

fit all the datasets with a P > 0.1, which is even more
conservative measure than the P 5 0.05 value commonly
used as a cutoff for statistical significance. In these
analyses, a value lower than the p-value cutoff would suggest that the model is not consistent with the data. In the
majority of cases examined, we found that the data were
fit either by a linear (straight line) model or a relationship
which is linear at low dose and shows a saturation-like
downward curvature at high dose. These data included
micronucleus results in TK6 human B-lymphoblastoid
cells in vitro as well as MN induction in mice blood cells
in vivo. In other datasets, some degree of upward curvature was present in the data which was reflected in the
statistical modeling. However in these cases, the data
were still appropriately represented by models having
low-dose linear behavior. The low-dose linearity index for
all of these datasets was below 3. These data included
mutation and MNC frequency in AHH-1 human B-lymphoblastoid cells, mutant frequency in L5178Y/Tk1/mouse lymphoma cells and deletion mutations in the
kidneys of gpt delta rats. It is important to recognize that,
in some cases, statistical fitting of assay data can have
limited power to determine dose-response relationships.
We examined this issue in modeling the data on 8-OH-dG
kidney adduct levels in Big Blue rats. We found that an
alternative nonlinear model – a quadratic model with no
linear term – also provided an appropriate fit to the data,
indicating that these data had little power to resolve the
shape of the underlying dose-response relationship. Furthermore, the data on mutation and MNC frequency in
AHH-1 cells were also consistent with both, threshold
and low-dose linear models. As noted in the introduction,

our analyses were focused on examining the substantial
database relevant to dose-response patterns for the
genotoxic effects of KBrO3; we have not undertaken
evaluation of all the data and scientific issues that would
be included in a mode of action analysis for KBrO3 carcinogenicity.
As shown in the Appendix, Table A1, the generation of
8-OH-dG adducts is a common endpoint measured in
cell-free, in vitro cell culture and in vivo conditions. As it
is considered a primary effect of KBrO3 exposure, this
end point might be a good anchor for comparison of the
in vitro vs. in vivo effects of KBrO3; acute vs. continuous
exposure; and rat vs. human exposure. For purposes of
this article, measurements of this endpoint allow some
comparison of the effective cellular doses of KBrO3
between in vivo and in vitro conditions. For example in
two early studies by the same group [Sai et al., 1992,
1994] using the same species (male F344 rats), both in
vivo and in vitro experiments were performed. The
increase in 8-OH-dG in the kidney after a single in vivo
exposure to 80 mg/kg KBrO3 by intraperitoneal injection
(48 hr after treatment) was comparable with the increase
of 8-OH-dG observed in an in vitro preparation of kidney
proximal tubules exposed to 5 mM KBrO3 for 4 hr (Appendix, Table A1). Although such comparisons can give
some guidance for extrapolation from one type of study
to another, consistency among studies and potential differences in bioactivation are important factors to be considered. It is important to note that in some earlier studies
the background levels of 8-OH-dG might be elevated artifactually during DNA isolation and enzymatic digestion.
Also it is important to account for possible saturation at
high doses, in which case, the lowest dose that produces
the maximal effect can be used in making comparisons.
As a tool to provide insight into different factors that
may affect the observed shapes of dose-response relationships, we also developed a biochemical kinetic model of
KBrO3-induced DNA damage (Fig. 7). We did not
attempt to incorporate all available biological information
in our model, but to develop a simplified model that illustrates a basic phenomenon. We were interested to study
the possible dose-response shapes of downstream events,
when an upstream event has a sublinear shape. This is an
important question to be investigated, as in some cases
the presence of a nonlinearity or apparent threshold in an
early upstream event is used as a reason to conclude that
downstream events also have a threshold. For this purpose
not all biochemical reactions are represented in detail in
the model and in some cases a reaction in the model
includes several biochemical steps. In our model, KBrO3
can interact reversibly with GSH to form reactive oxygen
intermediates (BrOI) that can directly cause oxidative
DNA damage (Fig. 7A). Even though some evidence suggests that BrOI can directly generate SSB [Ballmaier and
Epe, 1995; Ballmaier and Epe, 2006], we only considered
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Fig. 7. KBrO3 – DNA damage mechanism. A: The model depicts a process of DNA damage, where the initial step is dG base oxidation by a
KBrO3-GSH interaction intermediate product (BrOI). (B and C) Simulation based on the model in (A) with base-excision repair mechanism initiated by Ogg1 (OGG1R) included in the model simulation presented in
(C) but not in (B). The simulation responses are normalized by the maximum adducts observed in absence of repair within the dose range
explored. In (B), the dose-response curve is shown for the formation of
8-OH-dG adducts in the absence of an effective base-excision repair
mechanism (-OGG1R). In (C), SSB are generated subsequent to the
DNA oxidation as a byproduct of an unsuccessful DNA repair (see

text). In such a scenario, the 8-OH-dG is increasingly repaired with time
after exposure, while SSB continuously accumulate. Dose-response
curves are shown for both adducts (solid line) and single strand breaks
(dashed line) in the presence of repair. The dose-response profiles for 8OH-dG and SSB were computed at a time point after the KBrO3 exposure, shortly before the steady state is reached. The figure demonstrates
that even if an upstream endpoint (8-OH-dG) might present with sublinear/threshold like dose-response dependence, a downstream process of
SSB generation can have linear dose-response dependence. Note the difference in scales for 8-OH-dG and SSB (SSB is only a small fraction of
8-OH-dG).

the BrOI induction of 8-OH-dG here for simplicity.
Further, in our model, 8-OH-dG adducts are being
repaired by a BER mechanism (labeled OGG1R) that
consists of Ogg1 base-excision as an initial step. In some
cases the repair process proceeds to produce an intact
DNA strand, while in other rare cases, further repair fails
and leaves persistent unrepaired SSB (Fig. 7A). In our
model, all reactions have fixed rate constants (see Methods). Therefore, according to the mass action law, the increment of SSB per unit time is proportional to the adduct/
BER complexes (d[SSB]/dt 5k[8-OH-dG.OGG1R]). We
also assumed that SSB were formed from 8-OH-dG and
not as a result of increased BER activity. We performed a

computer simulation based on this model using a MATLAB
script (available upon request). KBrO3 at different concentrations was applied at the beginning of the simulated
experiment for a short time. The dose-response profile for
8-OH-dG and SSB was computed at a time point after the
KBrO3 exposure, shortly before the steady state is reached.
As illustrated in Figure 7C, the 8-OH-dG dose dependence
appeared to have highly sublinear behavior due to extensive
repair. However the SSB dose-response showed close to linear dependence and is completely linear at steady state,
when repair processes are completed (not shown). The
results from our model have fundamental implications.
They demonstrate that even if an early event in carcinogen-
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esis appears to have a highly sublinear threshold-like behavior, later downstream processes can still exhibit highly linear properties. This is important to consider in reaching
conclusions on the toxicity of a chemical based on early
genotoxic events.
The observed results for the dose-response patterns for
DNA damage and mutation presented here were seen
with an oxidative agent that (after biochemical reactions
that are not yet fully defined) directly targets DNA.
More generally, DNA may be exposed to oxidizing species (such as reactive oxygen species (ROS)), that are
generated from a variety of different biological processes. It may not be justified to assume that widely differing biological processes would lead to the same doseresponse patterns. Similar linear responses may not
occur for agents which, for example, result in generation
of ROS due to processes involving overt cellular toxicity
and death [Takahashi et al., 1998; Siesky et al., 2002;
Eastmond, 2008]. It is also fair to note that other scenarios, for example, effective scavenging of a reactive intermediate at low doses, could create an apparent threshold
for the 8-OH-dG generation but would not result in a
downstream event’s linear dependence on the dose. A
pertinent question is then whether dose-response information can be developed to relate the applied dose of a
test compound to an appropriate internal indicator of
effects resulting from the formation of ROS and other
oxidative species. If (at low doses) there is a proportional (linear) relationship between the applied dose of a
test agent and exposure of DNA to relevant types of
ROS and DNA damaging species in the target cell or
organ, our results lend support to an inference of a lowdose linear relationship for the observed DNA damage
and mutation. If on the other hand, the relationship
between applied dose and reactive species formation is
nonlinear (e.g., a threshold-type dose-response), non-linear dose-responses for genotoxic effects might likewise
be inferred. Such inferences would be contingent on having sufficient understanding of the biological system to
confidently link the observed genotoxic effects to the relevant types of reactive species being produced.
A classification of genotoxic endpoints in terms of
biomarkers of exposure vs. biomarkers of effect has
been proposed in the literature [Swenberg et al., 2008].
In such a paradigm, DNA adducts such as 8-OH-dG are
considered to be biomarkers of exposure, while irreversible mutations are defined as biomarkers of effect. For
some environmental chemicals, biomarkers of exposure
and effect were found to have different dose-response
shapes and background levels, where biomarkers of exposure dose-responses were mostly linear and extrapolated back to zero, while biomarkers of effect had a
background level above zero [Swenberg et al., 2008].
However, we did not observe this pattern in our analysis
of data on KBrO3.

Traditionally, dose-response studies of toxic chemicals
have been used to identify a no-observed-effect-level
(NOEL), which is often defined as the highest dose that
does not produce a statistically significant effect, and a
lowest-observed-effect-level (LOEL), the lowest dose
that shows a significant response. Frequently, this statistically based analysis is extended further by making a
presumption that a threshold occurs at the NOEL or at a
level between the NOEL and the LOEL. However, statistical dose-response modeling may not support such a
presumption. The analyses here offer examples of highquality datasets where NOELs were defined, but where
statistical modeling indicated the compatibility of the
data with a non-threshold, low-dose linear dose-response
pattern. Scientifically, this is not a surprising result—any
method will lose sensitivity to detect responses as the
magnitude of these response declines with decreasing
dose.
Generally, a design with more doses in the low dose
region, below but close to the LOEL, would improve the
power of the analysis to define the dose-response and
detect the presence of a rapid change in response that
could be indicative of a threshold. Such a design will lead
to model fits with high slope indexes, if true thresholds
exist. In our analyses, most datasets had a number of
doses in the low response region that do improve their
ability to discern patterns of response at low dose. When
there is a strongly elevated response with a small variance
at the LOEL dose, this can serve to provide guidance for
further experimentation to define the response relationship
at lower doses (see for example, Fig. 4).
In summary, a systematic review of the literature and
analysis using dose-response modeling approaches
revealed that conclusions regarding the presence of a
threshold for the genotoxic effects of KBrO3 are premature and largely unsubstantiated. The datasets implicated
in earlier studies as demonstrating a threshold were shown
in our analyses to be consistent with low-dose linear models. Furthermore, our kinetic model simulations reveal
that even if an upstream genotoxic effect appears to have
a dose-response shape consistent with a threshold, downstream endpoints can still exhibit linear dose-response dependence.
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2 and 5 mM for 2 to 4h

10 to 20 mM for 1h
2 g/L for 12 weeks

20 and 100 mg/kg

500 mg/kg

500 mg/kg

0.5 g/L for more
than two generations
400 mg/kg
400 mg/kg
0.4 g/L for 3 weeks
20 and 80 mg/kg
60 to 500 ppm for up
to 13 weeks
15 to 500 ppm for
4 weeks
15 to 500 ppm for
4 weeks
300 mg/kg i.g intubation
and 80 mg/kg i.p.
injection - test at 48 h
100 to 400 mg/kg test at 48 h
100 to 400 mg/kg test at 48 h

8-OH-dG

8-OH-dG
8-OH-dG

8-OH-dG

8-OH-dG

8-OH-dG

8-OH-dG

8-OH-dG

8-OH-dG

8-OH-dG

8-OH-dG

8-OH-dG

8-OH-dG
8-OH-dG
8-OH-dG
8-OH-dG
8-OH-dG

8-OH-dG

8-OH-dG

8-OH-dG
8-OH-dG
8-OH-dG

1 mM 12 mM GSH
for 2h
0.5 to 2 mM for 4 h
0.5 to 2 mM for 4 h
15 lM to 1.5 mM with
500 lM GSH
15 lM to 1.5 mM for
15 min, 378C
with 500 lM GSH
1.5 mM

Dose

8-OH-dG

Test

vivo
vivo
vivo
vivo
vivo

in vivo

in vivo

in vivo

in vivo

in vivo

in
in
in
in
in

in vivo

in vivo

in vivo

in vivo

in vitro
in vivo

in vitro

in vitro

in vitro

in vitro
in vitro
in vitro

cell free

System level

i.g.

i.g.

intub; i.p.

DW

DW

i.g.
i.g.
DW
i.p.
DW

DW

i.p.

i.p.

i.p.

NA
DW

NA

NA

NA

NA
NA
NA

NA

Route

Species/Organ

female F344 rats/liver

female F344 rats/kidneys

female F344 rats

male F344 rats/kidney

female F344 rats/kidney

F344 rats/kidney
F344 rats/liver
Long-Evans rats/kidney
male F344 rats/kidney
gpt delta rats/kidney

FX PM mice/oocytes

Sprague–Dawley rat/liver

Sprague–Dawley rat/kidney

rat kidney epithelial cells
(NRK-52E)
male F344 rat/renal
proximal tubules
V79 Chinese hamster cells
gpt/Ogg1 1/- and gpt/Ogg1
-/- mice/kidney
Sprague–Dawley rat/kidney

calf thymus DNA

HL-60 cell culture
HP-100 cell culture
calf thymus DNA

calf thymus DNA

TABLE AI. DNA Damage by KBrO3 Exposure Measured by Various Assays

4.2/105 dG
4.1/105 dG
(91 6 33)/105 dG
90/105 dG

(10.2 6 0.5)/105 dG
(4.8 6 0.71)/105 dG
(3.07 6 0.43)/105 dG
45.73/105 dG
(2.3 6 0.31)/105 dG and
(35.5 6 13.0)/105 dG
in mitochondria - 24h
after injection
138/105 dG (27 weeks
after injection)
42/105 dG (24 weeks
after injection)
3-fold increase over control
(measured with antibody)
5.8/105 dG (24h)
2.44/105 dG
0.162/105 dG
(8.7 6 1.2)/105 dG at 48 h
(0.88 6 0.10)/105 dG
at 5 weeks
(0.70 6 0.16)/105 dG
(0.71 6 0.21)/105 dG
i.g. 0.87/105 dG
i.p. 0.76/105 dG
(1.54 6 0.15)/105 dG
0.56/105 dG (not significantly
different from control)

0.3/105 dG
0.4/105 dG
(8 6 1)/105 dG
8/105 dG

(2.8 6 0.3)/105 dG
(0.98 6 0.22)/105 dG
(0.51 6 0.15)/105 dG
0.22/105dG
(1.12 6 0.28)/105 dG
and (22.5 6 3.1)/105
dG in mitochondria

(0.31 6 0.06)/105 dG
0.33/105 dG

(0.37 6 0.10)/105 dG
0.49/105 dG

(0.25 6 0.05)/105 dG

1.3/105 dG
1.5/105 dG
not detected
(2.7 6 0.67)/105
(0.28 6 0.06)/105 dG

NA

5/105 dG

5/105 dG

434/105 dG

Max Effect

4/105 dG

Control effect

[Umemura et al., 1995]

[Umemura et al., 1995]

[Umemura et al., 2004]

[Umemura et al., 2004]

[Umemura et al., 2004]

[Entezam et al.,
2010]
[Kasai et al., 1987]
[Kasai et al., 1987]
[McDorman et al., 2005]
[Sai et al., 1992]
[Umemura et al., 2006]

[Cho et al., 1993]

[Cho et al., 1993]

[Chipman et al., 1998]

[Speit et al., 1999]
[Arai et al., 2002]

[Parsons and Chipman,
2000]
[Sai et al., 1994]

[Murata et al., 2001]
[Murata et al., 2001]
[Parsons and Chipman,
2000]
[Chipman et al., 1998]

[Murata et al., 2001]

Reference

15 lM to 1.5 mM for
15 min, 378C
2 g/L for 12 weeks

0.625 to 10 mM for 3h

0.5 to 5 mM for 4h

2.5 to 5 mM for 20h

5 mM

1 p.o. at 160 mg/kg
and 3 p.o.
at 107 mg/kg
0.56 to 1.8 mM

0.56 to 1.8 mM

1 mM to 20 mM
200 and 400 mg/kg

160 mg/kg

160 mg/kg

160 mg/kg

0.06 to 3 mM for 4 h

0.5 to 4 mM for 3h

8-OH-dG

COM

COM

COM

COM

COM

COM

COM

COM
COM

COM

COM

COM

MF

MF(TK,HPRT)

8-OH-dG

8-OH-dG

8-OH-dG

500 ppm in drinking
water
0.02 to 500 ppm for
16 weeks (0.53 to
13,774 lg/rat/day)
5 mM for 15 min and 1h

Dose

8-OH-dG

Test

in vitro

in vitro

in vivo

in vivo

in vivo

in vitro
in vitro

in vitro

in vitro

in vivo

in vitro

in vitro

in vitro

in vitro

in vivo

in vitro

in situ

in vivo

in vivo

System level

NA

NA

oral

oral

oral

NA
NA

NA

NA

oral

NA

NA

NA

NA

DW

NA

NA

DW

DW

Route

primary cultures of human
kidney cells
primary cultures of
Sprague–Dawley
male albino rat
kidney cells
V79 Chinese hamster cells
kidney cells from OFA
Sprague–Dawley
male rats
Male Sprague–Dawley
rats/thyroid
Male Sprague–Dawley
rats/liver
Male Sprague–Dawley
rats/kidney
L5178Y/Tk1/2 mouse
lymphoma cells
mouse lymphoma
L5178Y cells

Sprague–Dawley male
albino rats/kidney

human lymphoblastoid
TK6 cells
primary cultures of human
thyroid cells
human white blood cells

gpt/Ogg1 1/- and
gpt/Ogg1 -/- mice/liver
CHO cells

calf thymus DNA

Sprague–Dawley
rat/kidney

Big Blue rats/kidney

rats/kidney

Species/Organ

TABLE AI. DNA Damage by KBrO3 Exposure Measured by Various Assays (Continued)

11.35/105 dG
OTM 5 23.8; when highly
damaged cells excluded
OTM 5 16.42 6 1.41
TL: 37.2 lm
TL: (9.9 6 3.5) lm

(2.3 6 1.1)/105 dG
and (21.0 6 8.9)/105
dG for mitochondria
8/105 dG (500 mM GSH)
1.64/105 dG
OTM 5 1.15; when highly
damaged cells excluded,
OTM 5 0.72 6 0.15
TL: 9.7 lm
TL: (1.9 6 0.4) lm

TM: 4.15
Median OTM 1.22

TL: (19.3 6 3.1) lm
TL: (4.5 6 0.8) lm
TL: (19.1 6 1.3) lm
1483/106 surviving cells
4127/106 tk; 16.7/106 hprt

TL: (1.8 6 0.7) lm
TL: (2.5 6 0.4) lm
TL: (2.2 6 0.6) lm
111/106 surviving cells
90/106 tk; 1.5/106 hprt

TL: (46.56 19.5) lm;
TM: 356961481
TL: (41.1 6 18.4) lm;
TM: 326761601

TL: (6.66 2.2) lm;
TM: 7126231
TL: (3.6 6 3.2) lm;
TM: 3396301

TM: 0.1
Median OTM 0.89

TL: (4.7 6 12.1) lm and
(16.9 6 23.2) lm

TL: (3.2 6 10.8) lm

7% tail increase

(3.56 6 0.88)/105 dG and
(25.7 6 13.9)/105 dG for
mitochondria
90/105 dG (500 lM GSH)

(0.75 6 0.18)/105 dG

Max Effect
1.84/105 dG (3 weeks
treatment)
(1.4 6 0.22)/105 dG

0.8/105 dG

Control effect

[Harrington-Brock et al.,
2003]
[Priestley et al., 2010]

[Mattioli et al., 2006]

[Mattioli et al., 2006]

[Mattioli et al., 2006]

[Speit et al., 1999]
[Nesslany et al., 2007]

[Robbiano et al., 1999]

[Robbiano et al., 1999]

[Parsons and Chipman,
2000]
[Robbiano et al., 1999]

[Mattioli et al.,2006]

[Luan et al., 2007]

[Poul et al., 2004]

[Arai et al., 2003]

[Chipman et al., 1998]

[Chipman et al., 1998]

[Yamaguchi et al., 2008]

[Umemura et al., 1995]

Reference

5 mM to 20 mM for 1h
2 g/L for 12 weeks

2 g/L for 12 weeks

0.02 to 500 ppm for
16 weeks (0.53 to
13774 lg/rat/day)
60 to 500 ppm for
up to 13 weeks

MF (HPRT)
MF (gtp)

MF (gtp)

MF (lacl)

in vitro

400 to 550 lg/ml for
24 and 48h
0.56 to 1.8 mM

0.56 to 1.8 mM

0.08-0.8 g/L for
8,78 weeks
18.8 to212 mg/kg

37.5 to 300 mg/kg

18.8 to 150 mg/kg

160 mg/kg p.o.

0.1 to 1 mM for
15 min, 378C

MN

MN

MN

MN

MN

MN

REL

cell free

in vivo

in vivo

in vivo

in vivo

NA

oral

i.p.

i.g.

i.p.

DW

NA

NA

NA

NA

NA

NA
NA

DW

DW

DW

NA
DW

NA

Route

CHO cells
mouse lymphoma
L5178Y cells
human lymphoblastoid
TK6 cells
TK6 human
lymphoblastoid cells
human peripheral blood
lymphocytes
primary cultures of human
kidney cells
primary cultures of
Sprague–Dawley
male albino rat kidney cells
B6C3F1 mice/normochromatic
erythrocyte
CD-l male mice/peripheral
blood reticulocytes
(PB-RETs)
MS/Ae and CD-1 mice/
polychromatic erythrocytes
MS/Ae and CD-1
mice/polychromatic
erythrocytes
Sprague–Dawley male
albino rats/kidney
bacteriophage PM2 DNA

gpt delta rats/kidney

human lymphoblastoid
TK6 cells
V79 Chinese hamster cells
gpt/Ogg1 1/- and gpt/Ogg1
-/- mice/liver
gpt/Ogg1 1/- and gpt/Ogg1
-/- mice/kidney
Big Blue rats/kidney

Species/Organ

(61.9 6 24.0)/106

(0.99 6 0.45)/105

(22.4 6 12.2)/106

(0.28 6 0.16)/105

[Nakajima et al., 1989]
[Nakajima et al., 1989]

(6.1 6 0.08)/1000
(23.4 6 3.6)/1000

(2.28 6 1.23)/100
(3.78 6 0.97)/100

(2.81 6 1.18)/1000
1.25 modifications/104 bp
(2 mM GSH)

(1.40 6 0.02)/1000
(1.6 6 0.9)/1000

(0.23 6 0.22)/100
(0.3010.14)/100

(0.73 6 0.49)/1000
0.1 modifications/104 bp
(2 mM GSH)

[Ballmaier and Epe,
2006]

[Robbiano et al., 1999]

[Awogi et al., 1992]

[Allen et al., 2000]

[Robbiano et al., 1999]

(11.4 6 4.29)/1000

2.11/1000
(1.77 6 1.04)/1000

[Kaya and Topaktas,
2007]
[Robbiano et al., 1999]

[Platel et al., 2009]

[Luan et al., 2007]

(1.1 6 0.18)/100
(at 500 lg/ml)
9.47/1000

0.067

83.5/1000

[Umemura and
Kurokawa,
2006]
[Poul et al., 2004]
[Priestley et al., 2010]

[Yamaguchi et al., 2008]

[Arai et al., 2002]

[Speit et al., 1999]
[Arai et al., 2003]

[Luan et al., 2007]

Reference

(0.18 6 0.02)/100

0.01

3.5/1000

34.2% MNBN
6%

72/106
(35.5 6 15.7)/106 after
liver regeneration
(28.8 6 6.5)/106

4/106
(11.9 6 6.10)/106 after
liver regeneration
(2.96 1.0)/106

2.2% MNBN
0.40%

63.5/106

Max Effect

2.76/106

Control effect

8-OHdG, 8-hydroxy-2’-deoxyguanosine (includes its tautomer 8-oxo-2’deoxyguanosine); Gtp, mutations affecting the gtp gene; i.g, single intragastric administrations; i.p., intraperitoneal injection; DW, drinking
water; COM, comet assay; MN, micronucleus assay; MF, mutant frequency; HPRT, mutations at the HPRT locus; REL, relaxation assay; Spi, mutations affecting the Spi gene; TK, thymidine kinase (TK) gene
mutation assay; Lacl, mutation frequencies of LacI gene; (O)TM, (Olive) tail moment; TL, tail length.

MN

in vivo

in vitro

in vitro

in vitro

6.25 lM to 1 mM

MN

MN

in vitro

0.5 to 5 mM for 4h

MN

in vitro
in vitro

0.625 to 10 mM for 3h
0.5 to 4 mM for 3h

in vivo

in vivo

in vivo

in vitro
in vivo

in vitro

System level

MN
MN

MF (Spi-)

0.5 to 5 mM for 4hr

Dose

MF (TK)

Test

TABLE AI. DNA Damage by KBrO3 Exposure Measured by Various Assays (Continued)

